^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Cholangiocarcinoma
    Drug:gemcitabine (DNA synthesis inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Biliary Tract Cancer: Other Recommended Regimens…Gemcitabine (gallbladder and intrahepatic cholangiocarcinoma only)
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    ESMO.org
    Title:

    Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆

    Excerpt:
    Recommendations...Gemcitabine monotherapy may be used in patients with a PS of 2 [IV, B].